BioLine Rx | 6-K: Report of foreign private issuer (related to financial reporting)
BioLine Rx | 6-K: Report of foreign private issuer (related to financial reporting)
BioLine Rx | 20-F/A: Registration statement / Annual report / Transition report (Amendment)
BioLine Rx | 20-F: Registration statement / Annual report / Transition report
BioLine Rx | 6-K: Report of foreign private issuer (related to financial reporting)
BioLine Rx | 6-K: Report of foreign private issuer (related to financial reporting)
BioLine Rx | 6-K: Report of foreign private issuer (related to financial reporting)
BioLine Rx | 6-K: Report of foreign private issuer (related to financial reporting)
BioLine Rx | 6-K: Report of foreign private issuer (related to financial reporting)
BioLine Rx | 6-K: Report of foreign private issuer (related to financial reporting)
BioLine Rx: FY2022 Annual Report
20-F | BioLineRx Ltd. (0001498403) (Filer)
BioLine Rx | 6-K: Report of foreign private issuer (related to financial reporting)
BioLine Rx | 6-K: Report of foreign private issuer (related to financial reporting)
BioLine Rx | 6-K: Report of foreign private issuer (related to financial reporting)
BioLine Rx | 6-K: Report of foreign private issuer (related to financial reporting)
BioLine Rx | 20-F/A: Registration statement / Annual report / Transition report (Amendment)
BioLine Rx | 6-K: Report of foreign private issuer (related to financial reporting)
BioLine Rx | 6-K: Report of foreign private issuer (related to financial reporting)
BioLine Rx | 6-K: Report of foreign private issuer (related to financial reporting)
BioLine Rx | 20-F: FY2021 Annual Report
No Data